Skip to main content
Erschienen in: Reactions Weekly 1/2019

01.08.2019 | Case report

Heparin/immune globulin/methylprednisolone

Lack of efficacy: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Tinti MG, et al. Eculizumab in refractory catastrophic antiphospholipid syndrome: a case report and systematic review of the literature. Clinical and Experimental Medicine 19: 281-288, No. 3, Aug 2019. Available from: URL: http://doi.org/10.1007/s10238-019-00565-8 - Italy Tinti MG, et al. Eculizumab in refractory catastrophic antiphospholipid syndrome: a case report and systematic review of the literature. Clinical and Experimental Medicine 19: 281-288, No. 3, Aug 2019. Available from: URL: http://​doi.​org/​10.​1007/​s10238-019-00565-8 - Italy
Metadaten
Titel
Heparin/immune globulin/methylprednisolone
Lack of efficacy: case report
Publikationsdatum
01.08.2019
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2019
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-019-65939-6

Weitere Artikel der Ausgabe 1/2019

Reactions Weekly 1/2019 Zur Ausgabe

Case report

Rivastigmine

Case report

Alteplase

Case report

Interferon-α-2a